Longitudinal Investigation of Cancer-related Fatigue
NCT03211273 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2019-08-28
Summary
In the LIFT study 2000 cancer patients will be recruited at 6 months after diagnosis and extensively surveyed over five years on factors that are associated with fatigue.
Conditions
- Cancer-related Fatigue
Sponsors & Collaborators
-
University Hospital Heidelberg
collaborator OTHER -
German Cancer Research Center
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-03-31
- Primary Completion
- 2021-06-30
- Completion
- 2025-06-30
More Related Trials
-
Impact on Quality of Life, Fatigue and Cognitive Function in Anti-angiogenesis in Patients With Metastatic Kidney Cancer
NCT01336231 ·Status: TERMINATED
-
FLT-PET for Early Detection of Relapse in Patients With Irradiated Lung Cancer
NCT02995889 ·Status: COMPLETED ·Phase: NA
-
PET Scans and CT Scans in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy
NCT00388024 ·Status: COMPLETED
-
Tumor Metabolism of Lung Cancer in Patients Who Underwent Percutaneous Radiation Measured With F-18-FDG-PET
NCT00180154 ·Status: COMPLETED
-
Performance of 18F-FDG Micro-PET-CT in the Assessment of Surgical Margins in Head and Neck Cancer
NCT07285564 ·Status: RECRUITING ·Phase: NA
-
18F-DCFPyL PET-CT Scan and Prostate Cancer
NCT03852654 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Functional Imaging of Tumor and Normal Tissue
NCT00933114 ·Status: TERMINATED
-
PET/MR Imaging in Lung Cancer
NCT03739281 ·Status: TERMINATED ·Phase: NA
-
An International Study on the Use of PET/CT in Radiotherapy Planning in Low and Middle Income Countries
NCT02247713 ·Status: UNKNOWN
-
Lung Perfusion PET / CT Using Ga68-MAA for Preservation of Lung Function During Stereotactic Pulmonary Radiation Therapy
NCT04942275 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Evaluation of 68Ga-FAPI-46 and 18F-FDG PET/CT Imaging for Detecting Recurrent Tumor Lesions in Patients of Ovarian Cancer
NCT06232122 ·Status: RECRUITING ·Phase: NA
-
Non-invasive MRI Subclassification of Heptocellular Carcinoma - HepCaSt-Study
NCT05202015 ·Status: UNKNOWN
-
Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgkin's Lymphoma
NCT00775957 ·Status: TERMINATED
-
Comaprison of 68Ga-FAP-2286 and 18F-FDG PET/CT in Patients With Various Types of Cancer
NCT05392205 ·Status: COMPLETED ·Phase: NA
-
68Ga-FAPI-46 PET for Imaging of FAP Expressing Cancer
NCT05160051 ·Status: COMPLETED ·Phase: PHASE2
-
[68Ga]Ga-PentixaFor PET Imaging in CNS Lymphoma Patients
NCT05222269 ·Status: TERMINATED ·Phase: PHASE2
-
[68Ga]Ga-PSMA PET/CT in Hepatocellular Carcinoma: Impact of Multiparametric Dynamic Whole-body Imaging and Kinetic Modeling.
NCT06999837 ·Status: RECRUITING ·Phase: NA
-
18F-DCFPyL PET/MRI in Regional Nodal&Distant Metastases Detection in Intermediate &HR Prostate Cancer
NCT04809584 ·Status: APPROVED_FOR_MARKETING
-
PET TDM FDG-Choline as a Decision-making Tool for Routine Care on the Liver Transplant List for HCC
NCT04792801 ·Status: ACTIVE_NOT_RECRUITING
-
MPDL3280A-imaging-IST-UMCG
NCT02453984 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors
NCT06690216 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1/PHASE2
-
PET/MR Characterization of Renal Cell Carcinomas
NCT04271254 ·Status: TERMINATED ·Phase: NA
-
Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types
NCT06782412 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Clinical Research of 18F-Alfatide Ⅱ PET/CT in Breast Cancer
NCT02582801 ·Status: TERMINATED ·Phase: PHASE1
-
An Investigational Scan (MR DENSE) in Detecting Early Chemotherapy-Related Liver Injury Before Surgery in Patients With Resectable Colorectal Liver Metastases
NCT05059717 ·Status: WITHDRAWN ·Phase: NA